Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Extracorporeal Membrane Oxygenation Machine Market Size

ID: MRFR//6647-HCR | 95 Pages | Author: Rahul Gotadki| April 2024

The ECMO market is expected to reach USD 0.43 billion by 2030 at 5.1% CAGR from 2022-2030. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market is shaped by many factors. The increased prevalence of respiratory and cardiac failure, where ECMO saves lives, is a major cause. ECMO devices are in high demand as the global population ages and major respiratory and cardiovascular diseases increase. Advances in basic care medicine have led to improved understanding findings and a greater recognition of ECMO as a vital tool for managing complicated organ failure.

Administrative elements affect the ECMO market, ensuring their safety and sustainability. Strict restrictions govern ECMO machine approval, assembly, and use. These rules ensure patient safety and provide a reliable industrial structure, fostering confidence among medical professionals and foundations using ECMO for advanced life support.

Financial considerations including medical cost and repayment affect ECMO machine use. Medical care providers and payers like ECMO intercessions because they are cost-effective and reduce long-term medical expenses from delayed critical consideration stays. Market trends and ECMO innovation are affected by monetary factors.
Market trends are influenced by segment characteristics including aging and significant respiratory and cardiovascular conditions. Aging people are increasingly vulnerable to organ failure and need advanced life support like ECMO. The growing awareness of fundamental consideration intercessions and early recognition of organ failure patients further boosts ECMO machine interest.

Social attitudes concerning medical services and clinical mediations also shape the ECMO industry. Acknowledgement of advanced life support measures, adherence to treatment regimens, and societal perception of basic regard affect patient preferences and ECMO exploration. Social factors affect the ECMO usage dynamic cycle between medical providers and patients.

Medical services structure and openness vary geologically, adding market components. Creation and development sites may have different access to cutting-edge clinical medications like ECMO mediations. Executives aim to resolve these discrepancies by improving medical care framework, highlighting accessible therapeutic options, and providing ECMO training, affecting the global ECMO industry.

Covered Aspects:

Report Attribute/Metric Details
Growth Rate   5.10%

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Overview


The Extracorporeal Membrane Oxygenation Machine (ECMO) Market is expected to grow at a CAGR of 5.10% to reach USD 430 Million during the forecast period (2022 to 2030).


Patients who face difficulty to supply adequate oxygen to the heart and lungs in their body, gets help from Extracorporeal Membrane Oxygenation Machine. It provides respiratory support thus act as a life support machine to many people. A proper respiratory functioning is crucial for people suffering from life-threatening diseases; therefore, the Extracorporeal Membrane Oxygenation Machine comes to their use. The growing number of cardiovascular diseases and respiratory problems and the rapid increase in adoption of ECMO is the driving factor behind the growth of the extracorporeal membrane oxygenation machine market. Along with adoption of ECMO, increasing ECMO centres are also boosting the global market of ECMO.


According to the survey reports provided by the World Health Organisation (WHO), approx 306 hospitals in U.S had the facility of Extracorporeal Membrane Oxygenation Machine to provide respiratory support to people suffering from heart and lung diseases.


Complications regarding the usage of Extracorporeal Membrane Oxygenation Machine such as infections, bleeding or any kind of technical failure are prone to hinder the growth of extracorporeal membrane oxygenation (ecmo) machine market.


Covid-19 impact


The covid-19 pandemic has an impeccable effect all across the world. Many industries all around the globe has been affected by the sudden and infinite shutdown decision taken by the government. Many health industries have also been affected. However, the ECMO industry has seen positive impact during the pandemic situation.


Market dynamics


Drivers


The rising prevalence of diseases causing deaths are driving the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. Based on the reports of World Health Organisation (WHO), in 2012, around 17.5 millions died of Cardiovascular diseases all across the world. And, the number is anticipated to become more than 23.6 million by the end of 2030. It makes cardiovascular diseases as one of the leading causes behind the global death which is also boosting the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. Another prevalent disease is hypertension. It was the leading causes behind the cardiovascular diseases. According to WHO, in 2013, around 1 billion were suffering from hypertension. WHO also reported that chronic obstructive pulmonary diseases caused 3% of the entire deaths caused across the globe. Tobacco smoking and asthma are two of the major causes behind the increasing COPD which is also expected to rise high in the coming years.


ECMO is used to support people with all the cardiovascular problems. Therefore, the rising cases of such situations are the driving factors behind the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market.


Challenges


Although it works as a support system to patients of respiratory and cardiac problems, but the machine sometimes shows various complications.  For example, bleeding is the one of the most common complications associated with ECMO. The bleeding mainly happens because of a blood thinning drug called Heparin. Another complication associated with the extracorporeal membrane oxygenation machine (ecmo) is infection. Infections mostly occur because of the cannula being inserted in the blood vessels. Apart from that, the chances of a patient being infected increases drastically when he or she stays for a longer period of time in the hospital. Technical failure of the machine is also enlisted in all the complications related to the machine. About 4% of the mechanical failures happen because of air entering the ECMO circuit.


Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights


The market of Extracorporeal Membrane Oxygenation Machine is segmented into-



  • Component

  • Modality

  • Application

  • Region


Extracorporeal Membrane Oxygenation Machine Component Insights


Base on component, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-



  • Pumps

  • Oxygenators

  • Controllers

  • Accessories

  • Cannula


The oxygenator segment is expected to hold  the largest market share of Extracorporeal Membrane Oxygenation Machine.


Extracorporeal Membrane Oxygenation Machine Modality Insights


Base on modality, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-



  • Veno-Arterial (VA)

  • Veno-Venous (VV)

  • Arterio-Venous (AV)


The Veno-Arterial (VA) segment is expected to hold  the largest market share of Extracorporeal Membrane Oxygenation Machine.


Extracorporeal Membrane Oxygenation Machine Application Insights


Base on application, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-



  • Respiratory

  • Cardiac

  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)


The respiratory segment is expected to hold  the largest market share of Extracorporeal Membrane Oxygenation Machine.


Extracorporeal Membrane Oxygenation Machine Region Insights


Base on region, the Extracorporeal Membrane Oxygenation Machine market is sub-segmented into-


North America


  • US

  • Canada


Europe


  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Europe


APAC


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Latin America


MEA (Middle East and Africa)


  • Middle East

  • Africa


Regional analysis


The North American market is expected to become the largest market for extracorporeal membrane oxygenation machine (ecmo). The rising diseases like lung cancer, increasing investment in research and developments, reimbursement scenarios are likely to boost the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market. U.S is the most dominating country of this region as it has the highest number of lung cancer. Therefore, the need for the ECMO is also highest in U.S. Apart from lung cancer, around 11 million people are diagnosed with COPD every year in U.S. Canada is also high in demand for the extracorporeal membrane oxygenation machine (ecmo).


The European extracorporeal membrane oxygenation machine (ecmo) market is about to show a substantial growth during the forecast period. It has the presence of many healthcare systems and rising chronic diseases, are driving the market growth of the region. Many key players being present in the market and their investments in research and developments is also propelling the growth of the European extracorporeal membrane oxygenation machine (ecmo) market.


The Asia-Pacific is anticipated to be the fastest-growing region in the extracorporeal membrane oxygenation machine (ecmo) market. The rising cases of lung cancer and cardiovascular diseases are also boosting the growth of the market. In China, 35.1% of the entire population are diagnosed with lung cancer every year. The favourable reimbursement scenario in Japan, growing ECMO service centres in India, and rising cases of lung cancer in China are proving the impetus to the Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market.


The MEA market of extracorporeal membrane oxygenation machine (ecmo) is expected to see the lowest growth among all the other regional markets.


Major key players



  • Getinge Group (sweden)

  • Medtronic plc (Ireland)

  • Livanova PLC (U.K)

  • Abbott, Agilent Technologies

  • Siemens AG

  • Terumo Corporation (Japan),

  • Fresenius Medical Care AG & Co. KGaA

  • Microport Scientific Corporation (China)

  • Nipro Corporation (Japan)

  • ALung Technologies Inc. (Germany)

  • MAQUET Holding B.V. & Co. KG

  • Medos Medizintechnik AG

  • Terumo Cardiovascular Systems Corp

  • XENIOS AG (Germany)

  • OriGen Biomedical, Inc. (U.S.)

  • EUROSETS S.r.l. (Italy)


Report overview



  • Market overview

  • Covid-19 impact

  • Market dynamics

  • Drivers

  • Challenges

  • Restrains

  • Opportunities

  • Technological analysis

  • Segmentation overview

  • Regional analysis

  • Competitive landscape

  • Recent developments

  • Major key players

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.